Hygiena 2020, 65(2):78-79 | DOI: 10.21101/hygiena.a1756

Coronavirus and smoking

Eva Králíková1,2
1 Univerzita Karlova, 1. lékařská fakulta, Ústav hygieny a epidemiologie a Všeobecná fakultní nemocnice v Praze, Praha, Česká republika
2 Univerzita Karlova, 1. lékařská fakulta, III. interní klinika - klinika endokrinologie a metabolismu, Centrum pro závislé na tabáku a Všeobecná fakultní nemocnice v Praze, Praha, Česká republika

Early publications on the characteristics of diagnosed patients with the new type of SARS CoV-19 coronavirus indicate a lower proportion of smokers compared to prevalence in the given populations, although smoking status is very rarely reported. Hospitalised smokers, on the other hand, have more severe disease progression than non-smokers and are at higher risk of death, particularly the complications in which smoking is involved, such as hypertension, diabetes mellitus, renal or cardiovascular failure. Also, the relationship of smoking with the ACE2 receptors is discussed. We do not know the possible misleading and confounding factors or the exact data on current or former smoking, so no clear opinion can be given in this context so far. However, the recommendation not to smoke is still valid.

Keywords: smoking, coronavirus SARS-CoV-2

Received: April 2020; Accepted: April 21, 2020; Published: May 31, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Králíková E. Coronavirus and smoking. Hygiena. 2020;65(2):78-79. doi: 10.21101/hygiena.a1756.
Download citation

References

  1. Global Adult Tobacco Survey [Internet]. Beijing: WHO; 23 May 2019. [cited 2020 Apr 17]. Fact Sheet China, 2018. Available from: https://www.tobaccofreekids.org/assets/global/pdfs/en/GATS_China_2018_FactSheet.pdf.
  2. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020 Feb 19. doi: 10.1111/all.14238. Go to original source... Go to PubMed...
  3. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 Feb 28. doi: 10.1056/NEJMoa2002032. Go to original source... Go to PubMed...
  4. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. Go to original source... Go to PubMed...
  5. Liu W, Tao ZW, Lei W, Ming-Li Y, Kui L, Ling Z, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020 Feb 28. doi: 10.1097/CM9.0000000000000775. Go to original source... Go to PubMed...
  6. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-62. Go to original source... Go to PubMed...
  7. Vardavas CI, Nikitara K. COVID-19 and smoking: a systematic review of the evidence. Tob Induc Dis. 2020 Mar 20;18:20. doi: 10.18332/tid/119324. Go to original source... Go to PubMed...
  8. Farsalinos K, Barbouni A, Niaura R. Smoking, vaping and hospitalization for COVID-19. Qeios. 2020 Mar 25. doi: 10.32388/Z69O8A.12. Go to original source...
  9. Petrilli CM, Jones SA, Yang J, Rajagopalan H, O'Donnell LF, Chernyak Y, et al. Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. medRxiv. 2020 Apr 11. doi: 10.1101/2020.04.08.20057794. Go to original source...
  10. Bean D, Kraljevic Z, Searle T et al. Bean D, Kraljevic Z, Searle T, Bendayan R, Pickles A, Folarin A, et al. Treatment with ACE-inhibitors is associated with less severe disease with SARS-Covid-19 infection in a multi-site UK acute Hospital Trust. ResearchGate. 2020 Mar. doi: 10.13140/RG.2.2.34883.14889/1. Go to original source...